Compass Therapeutics CMPX
NASDAQ CMPX
$1.10 -0.01 (-1.36%)
As of: Sep 29, 2026 · 3:59 PM EDT

Compass Therapeutics (CMPX) FCF Margin (2024)

Updated

Compass Therapeutics (CMPX) reported FCF Margin of -5282.24% for FY2024.

Analysis

Compass Therapeutics (CMPX) FCF Margin (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Compass Therapeutics 199.90 Mn 199.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,265.18%
API Access

Compass Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=CMPX&period=max&api_key=YOUR_API_KEY